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GENETIC EPIDEMIOLOGY OF SCHEUERMANN'S DISEASE
L. Oei, S. El Saddy, A.A. Makurthou, M.C. Castaño-Betancourt, K.
Estrada, A. Hofman, J.B. van Meurs, A.G. Uitterlinden, E.H. Oei, F.
Rivadeneira. Erasmus MC, Rotterdam, The Netherlands
Purpose: Scheuermann's disease is a form of osteochondrosis of the
spine, characterized by increased posterior rounding of the thoracic
spine in associationwith structural deformity of the vertebral elements.
Although the etiology remains largely unknown, there is evidence that
genetic factors play a role. A Danish twin study has found a heritability
estimate of 74%. Nevertheless, no associated genes have been found to
date. Our aim was to ﬁnd genetic susceptibility factors for Scheuer-
mann's disease.
Methods: The radiographic criteria of Sørensen, Hart and Sachs et al.
were applied to diagnose the Scheuermann's disease cases. Lateral
spine radiographs were available for 2,753 participants from a pop-
ulation-based study (age 45 years and over), of which 111 cases were
diagnosed with Scheuermann's disease. A genome-wide association
study (GWAS) was conducted by applying a logistic model adjusted for
sex and admixture principal components. To facilitate analysis of vari-
ants with lower allele frequency 1000 Genomes imputation (version:
06-2010) was applied.
Results:We found a SNP (minor allele frequency 3%) on chromosome 4
associated at genome-wide signiﬁcant level with radiographically
diagnosed Scheuermann's disease (P¼3.9 *10-8, odds ratio 5.3). The SNP
maps an intron of the tolloid-like-1 gene (TLL1). TLL1 is a protease that
shares structural similarity to BMP1 (Bone morphogenetic protein 1)
and is involved in collagen and chordin synthesis. TLL1 has been
described to induce formation of cartilage in vivo and it has a high
mRNA expression in the femoral growth plate.
Conclusions: This is the ﬁrst GWAS for radiographic Scheuermann's
disease, where we found a SNP associated at genome-wide signiﬁcant
level with Scheuermann's disease mapping to TLL1. Biologically
interesting is that TLL1 is a protease that is involved in collagen and
chordin synthesis and can induce formation of cartilage in vivo.
However, our GWAS had a small sample size because of the relatively
low disease prevalence the population-based study design resulted in
a limited sample size. A replication study is necessary to conﬁrm this
ﬁnding.328
EPIGENETIC REGULATION DURING FETAL FEMUR DEVELOPMENT:
DNA METHYLATION MATTERS
M.C. de Andrés y,z, E. Kingham y, K. Imagawa y,x, A. Gonzalez z, J.J. Gomez-
Reino z, H.I. Roach y, D.I. Wilson y, R.O. Oreffo y,k. yUniv. of Southampton.
Sch. of Med., Southampton, United Kingdom; z Inst. de Investigación
Sanitaria-Hosp. Clínico, Santiago de Compostela, Spain; x Tohoku Univ.
Sch. of Med., Sendai, Japan; k Stem Cell Unit. Coll. of Med., King Saud
University, Saudi Arabia
Purpose: Epigenetic modiﬁcations are heritable changes in gene
expression without changes in DNA sequence. DNA methylation has
been implicated in the control of several cellular processes including
differentiation, gene regulation, development, genomic imprinting and
X-chromosome inactivation. Methylated cytosine residues at CpG
dinucleotides are commonly associated with gene repression;
conversely, strategic loss of methylation during development could lead
to activation of lineage-speciﬁc genes. To date, there is a paucity of
information regarding the role of DNA methylation in the differentia-
tion of adult human skeletal cells, although some recent studies suggest
that it is involved in the regulation of some bone genes, as well as in
bone cell differentiation. In order to explore a potential link between
DNA methylation changes in gene expression observed during fetal
development, we selected genes that we have previously reported to be
associated with osteoarthritis (OA) and somehow epigenetically
regulated.
Objective: To examine a spectrum of developmental stages of femur
development and the role of DNA methylation therein of genes impli-
cated in bone biology.Methods: Human embryonic stem cells, human fetal bone cells
(HFBCs), adult chondrocytes and STRO-1+ marrow stromal cells from
human bone marrow were collected with informed patient consent
and the permission of the Local Ethics Committee. Genomic DNA
and total RNA were extracted simultaneously. By using pyrosequencing
methodology we analysed the status of methylation of genes
implicated in bone biology; furthermore, we correlated these
methylation levels with gene expression levels using qRT-PCR and
protein distribution during fetal development evaluated using
immunohistochemistry.
Results: We found that during fetal femur development DNA methyl-
ation inversely correlates with expression of physiological genes vital
for bone biology including iNOS and COL9A1 but, not catabolic/paho-
logic genes including MMP13 and IL1B. Furthermore, signiﬁcant
demethylation was evident in the osteocalcin promoter between the
fetal and adult developmental stages. Increased Tet1 expression and
decreased expression of DNA (cytosine-5-)-methyltransferase 1
(DNMT1) in adult chondrocytes compared to HFBCs could contribute to
the loss of methylation observed during fetal development.
Conclusions: HFBCs multipotency conﬁrms these cells to be an ideal
developmental system for investigation of DNA methylation regulation.
These ﬁndings highlight the role of epigenetic regulation, speciﬁcally
DNA methylation, in bone development, informing and opening new
possibilities in development of strategies for bone repair/tissue
engineering.329
EFFECT OF INHIBITORS OF SPECIFIC HISTONE DEACETYLASES (HDAC)
ON CHONDROCYTES
V. Ulici y, E. Zavadak z, R. Tuan y. yUniv. Of Pittsburgh, Pittsburgh, PA, USA;
zChatham Univ., Pittsburgh, PA, USA
Purpose: Osteoarthritis (OA), a multifactorial degenerative joint
disorder and the leading cause of disability in older adults, is caused by
the failure of chondrocytes to maintain the balance between cartilage
matrix synthesis and degradation, resulting in the predominance of
the latter. The role of epigenetic changes in OA has attracted increasing
attention. Higher HDAC expression has been reported in chondrocytes
from OA patients, associated with down-regulation of cartilage-
speciﬁc genes. In a rabbit OA model, pan-HDAC inhibitors, such as
Trichostatin A (TSA), reduced cartilage degradation compared to
control. In general, HDACs are suggested to play a negative role in
cartilage homeostasis and are possibly associated with OA. Previous
studies from our laboratory have shown beneﬁcial effects of pan-HDAC
inhibitors in in-vitro models of OA (supraphysiological mechanical
stimulation and IL1b-treated chondrocytes), such as decreased
expression of inﬂammatory mediators (e.g., inducible nitric oxide
synthase, iNOS) and of a number of matrix metalloproteinases (MMPs:
MMP13 and MMP1), but also some detrimental effects (increased COX-
2 expression and MMP3 expression/secretion). In addition, our
preliminary results have suggested that not all HDACs share the same
mechanism of action in chondrocytes (e.g., HDAC9 decreased after
mechanical stimulation vs other HDACs which were upregulated under
the same conditions). Therefore, we hypothesize that only speciﬁc
HDAC inhibitors (HDI) are effective chondroprotective agents with
minimal negative effects.
Methods: Adult bovine articular chondrocytes were cultured in high
density monolayer cultures (40,000 cells/cm2). The cells were then
treated for 24 h with 4 HDAC speciﬁc inhibitors (HDIs), Entinostat-
MS275 for HDAC1 and 3, Tubostatin A-6, PCI 34015 (PCI)-8 and
Droxinostat-3,6,8), at varying concentrations, and a pan-HDAC inhib-
itor (TSA). A broad range of concentrations was used in order to
analyze the effect of the HDIs on cell proliferation. Selected concen-
trations were used for subsequent experiments. Cellular RNA and
protein were harvested after treatment, followed by SYBR Green real-
time PCR (D-D Ct method) and Western blotting analysis. Culture
medium was also collected for Western blotting analysis. Live/Dead
and MTS assays were performed to assess the cytotoxic effects of the
HDIs.
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ment with all 4 HDIs, consistent with effective suppression of HDAC
activity. The most effective speciﬁc HDI was MS275, which showed
similar A-H3 levels to TSA, but exhibited some undesirable effects of
pan-HDI. PCI increased A-H3 levels, though not as effective as MS275,
but also reduced the negative effects of TSA, such as decreased COX-2
and MMP-3 expression under treatment with IL1b. Also, the additive
effect of TSA and IL1b on the secretion of MMP3was not observed in the
case of PCI. Chondrocyte proliferation and survival was unaffected by
the tested HDIs after 24 h of culture, with the exception of Droxinostat
at concentration over 20 mm(decreased proliferation as shown by MTS
assay and increased cell death as shown by Live/Dead assay). However,
upon longer incubation (48 h), both TSA (200 nM) and Droxinostat
reduced chondrocyte proliferation, while MS275, PCI and Tubostatin A
increased it.
Conclusions: The HDI, PCI, appears to be a promising candidate for
reducing inﬂammatory and catabolic markers in chondrocytes exposed
to pro-inﬂammatory cytokines. Further studies will investigate the
effect of increasing PCI concentrations in two in vitro chondrocyte-
based OA models: (1) IL1b treatment; and (2) exposure to supra-
physiological mechanical loading. In addition, MS275 could be a good
alternative to pan-HDAC inhibitors, such as TSA, when longer exposure
times are needed.
Grant support: Arthritis Foundation, Commonwealth of PA, Dept of
Health.330
REPLICATION STUDY OF OSTEOARTHRITIS SUSCEPTIBILITY GENES IN
HAND OSTEOARTHRITIS IN FINNISH WOMEN
S. Hämäläinen, S. Solovieva, T. Vehmas, P. Leino-Arjas, A.
Hirvonen. Finnish Inst. of Occupational Hlth., Helsinki, Finland
Purpose: Replication studies are needed to conﬁrm the osteoarthritis
(OA) susceptibility genes in different study populations and also in
different joint sites. We chose to analyze in our hand OA material 21
single nucleotide polymorphisms (SNPs) from 18 genes on which
there is suggestive evidence of an association with OA in different
joint sites.
Methods: Bilateral hand radiographs of 542 occupationally active
Finnish female dentists and teachers aged 45-63 years were examined
and classiﬁed for the presence of OA by using reference images. The
genotypes were determined by PCR-based methods. Data regarding
ﬁnger joint pain and other risk factors were collected by a question-
naire. Associations between the SNPs and hand OAwere studied by IBM
SPSS statistical package Version 20 using principle component analysis
based genetic weighted scores and logistic regression.
Results: The analysis resulted in 13 weighted genetic scores. When
adjusted for age, occupation, BMI and the other scores, score number 4,
including A2BP1 and COX2 SNPs, was associatedwith hand OA in at least
three joints (OR 0.67, 95% CI 0.48-0.94), and score number 8, containing
a TGFB1 SNP, with symptomatic DIP OA in at least 2 joints (OR 1.97, 95%
CI 1.11-3.49).
Conclusions: Our results give support to the earlier ﬁndings of A2BP1,
COX2 and TBGF1 being OA susceptibility genes, SNPs of which play an
important role in the etiology of hand OA in Finnish women.331
VARIATION IN OSTEOARTHRITIS BIOMARKER SERUM COMP LEVELS
IN MEXICAN AMERICANS IS ASSOCIATED WITH SNPS IN A REGION
OF CHROMOSOME 22Q ENCOMPASSING MICAL3, BCL2L13, AND BID
H.B. Coan y, J.E. Curran y, T.D. Dyer y, J.W. Kent, Jr. y, A. Choudary y, D.P.
Nicolella z, M.A. Carless y, S. Kumar y, M.A. Almeida y, R.
Duggirala y, D.C. Glahn x, M.C. Mahaney y, J. Blangero y, L.M.
Havill y. y Texas BioMed. Res. Inst., San Antonio, TX, USA; z Southwest Res.
Inst., San Antonio, TX, USA; xOlin Neuropsychiatry Res. Ctr., Institute of
Living, Hartford, CT, USA
Purpose: Many of the factors that account for variation in OA risk and
progression remain elusive, but there is growing consensus that
chondrocyte cell death plays a central role in disease pathogenesis. Weperformed association analyses in Mexican Americans from the San
Antonio Family Study – a group of family-based studies of complex
disease genetics – with all SNPs in a region of 22q including the
contiguous genes BCL2L13, BID, and MICAL3. This region has been
implicated in OA genetics in European populations and harbors two
candidate genes, BCL2L13 and BID, both of which are pro- apoptotic
members of the BCL-2 family of apoptosis proteins.
Methods:OA serum biomarkers such as COMP are valuable quantitative
endophenotypes for susceptibility gene localization and identiﬁcation.
They can reﬂect a broad range of disease pathogenesis, and being closer
to the direct action of genes, they may lead to more rapid discovery of
genes causally involved in OA risk. We measured COMP levels in stored
serum samples using ELISA (BioVendor R&D) in 840 individuals. We
tested for association between 428 SNPs in the region 500kb upstream,
downstream, and including MICAL3, BCL2L13, and BID and quantitative
variation in circulating COMP concentration using the software package
SOLAR.
Results: The effective number of SNPs in the region, considering LDwas
191, requiring p¼0.00027 for statistical signiﬁcance. Three SNPs,
rs1080199, rs2535707, and rs5992088 were signiﬁcantly associated
with variation in serum COMP levels. Each occurs in BCL2L13, and the
best SNP (rs1081099) explains w2.6% of the variance in COMP levels.
The average LD among the 3 SNPs is 0.94.
Conclusion: Our ﬁndings are consistent with those of others who have
reported associations of genes located in chromosome 22q with OA risk
and progression. Given that chondrocyte apoptosis is a feature of OA
pathogenesis and COMP is a potent suppressor of apoptosis in primary
chondrocytes, our result is particularly interesting in light of the pres-
ence of two pro-apoptotic genes in that region: BCL2L13 and BID.
Members of the BCL-2 family of proteins, they both function in the
mitochondrial apoptosis pathway, which is altered in OA. Chondrocyte
mitochondrial dysfunction has been observed in OA joints; conse-
quently, variants in BCL2L13, BID or even nearby MICAL3 could, by
extension, affect OA susceptibility and progression. It is encouraging
that the results of our study of data from Mexican American families
provides additional evidence that this region of chromosome 22q is
likely to harbor genes important to OA risk and also implicates bio-
logically promising candidate genes.332
CORRELATION BETWEEN CLINICAL AND RADIOGRAPHIC
CLASSIFICATION OF OSTEOARTHRITIS AND SNPS LINKED TO
OSTEOARTHRITIS SUSCEPTIBILITY
M. Saporito y, L. Minafra z,x, V. Bravatà z,x, F.P. Cammarata z,x, F.
Boniforti k. yUniv. of Palermo, Palermo, Italy; z LAboratorio Tecnologie
Oncologiche (LATO) - HSR (Cefalù – PA), Cefalù, Italy; x Inst. of Molecular
Bioimaging and Physiology - CNR IBFM, Cefalù - Segrate, Italy; kUnità
Operativa di Ortopedia, San Raffaele Hosp. “G. Giglio”, (Cefalù – PA),
Cefalù, Italy, Italy
Purpose: Osteoarthritis (OA) classiﬁcation is based mainly on clinical
and radiographic evaluations. Clinical examination can use speciﬁc
scores for each joint, such as the Knee Society Score (KSS), while the
Kellgren and Lawrence (KL) scale is commonly used for x-ray evalua-
tion. Today, proteogenomic studies have taken an increasingly signiﬁ-
cant role in the etiology of OA. Indeed, several authors have shown that
genetic and environmental factors could play a relevant role in OA not
yet classiﬁed. Moreover functional polymorphisms in frzb, matn3, aspn,
pthr2, gdf5 and dvwa genes increase susceptibility to OA development.
The aim of this study was to correlate clinical and radiographic grading
of OAwith molecular data. This study is based on the analysis of genetic
polymorphisms linked to OA susceptibility and proteogenomic analysis
in OA patients.
Methods: We enrolled 61 patients with primary OA, aged 54-86 years,
candidate for knee surgery with arthroscopy or arthroplasty. Clinical
evaluation was performed using the Knee Society Score: Knee Score
(KS) and Function Score (FS). The radiographic evaluation was per-
formed with the KL scale on anteroposterior and lateral x-ray views of
the knee. The classiﬁcation is synthesized into 3 groups: A (KL grade 1
and 2), B (grade 3), C (grade 4).
